1. Home
  2. RCKT vs HRTG Comparison

RCKT vs HRTG Comparison

Compare RCKT & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • HRTG
  • Stock Information
  • Founded
  • RCKT 1999
  • HRTG 2012
  • Country
  • RCKT United States
  • HRTG United States
  • Employees
  • RCKT N/A
  • HRTG N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • RCKT Health Care
  • HRTG Finance
  • Exchange
  • RCKT Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • RCKT 764.5M
  • HRTG 785.7M
  • IPO Year
  • RCKT N/A
  • HRTG 2014
  • Fundamental
  • Price
  • RCKT $2.77
  • HRTG $25.46
  • Analyst Decision
  • RCKT Buy
  • HRTG Buy
  • Analyst Count
  • RCKT 11
  • HRTG 3
  • Target Price
  • RCKT $21.77
  • HRTG $29.00
  • AVG Volume (30 Days)
  • RCKT 7.4M
  • HRTG 583.8K
  • Earning Date
  • RCKT 05-08-2025
  • HRTG 05-06-2025
  • Dividend Yield
  • RCKT N/A
  • HRTG N/A
  • EPS Growth
  • RCKT N/A
  • HRTG 52.27
  • EPS
  • RCKT N/A
  • HRTG 2.53
  • Revenue
  • RCKT N/A
  • HRTG $837,203,000.00
  • Revenue This Year
  • RCKT N/A
  • HRTG $6.73
  • Revenue Next Year
  • RCKT N/A
  • HRTG $7.30
  • P/E Ratio
  • RCKT N/A
  • HRTG $10.13
  • Revenue Growth
  • RCKT N/A
  • HRTG 11.64
  • 52 Week Low
  • RCKT $2.19
  • HRTG $6.14
  • 52 Week High
  • RCKT $26.98
  • HRTG $26.64
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.94
  • HRTG 64.94
  • Support Level
  • RCKT $2.19
  • HRTG $22.63
  • Resistance Level
  • RCKT $2.67
  • HRTG $24.24
  • Average True Range (ATR)
  • RCKT 0.54
  • HRTG 1.24
  • MACD
  • RCKT -0.45
  • HRTG -0.23
  • Stochastic Oscillator
  • RCKT 11.72
  • HRTG 73.64

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

Share on Social Networks: